Language

Medicine shortages: Czechia · Page 9

Official notices covering supply interruptions, limited availability and resumed supply. Each notice identifies the product, active ingredient, status and reported period.

Data checked:

970 notices · Page 9 / 20

← Europe overview

National authority sources: Czechia

Recorded notices include resolved cases. The data check date differs from the modification date of an individual authority notice.

Medicine shortages: Czechia · Page 9

Czechia

CHLORID SODNÝ B.BRAUN 0,9% 9MG/ML INF SOL 10X250ML II

Unterbrechung des Inverkehrbringens · Zvýšená spotřeba
Active ingredient: ELEKTROLYTY

Notice details →
Czechia

COSOPT 20MG/ML+5MG/ML OPH GTT SOL 1X5ML I

Marketing resumed · Not specified
Active ingredient: TIMOLOL, KOMBINACE

Notice details →
Czechia

DICLOFENAC AL 25MG TBL ENT 100

Marketing resumed · Not specified
Active ingredient: DIKLOFENAK

Notice details →
Czechia

DICLOFENAC AL 25MG TBL ENT 20

Marketing resumed · Not specified
Active ingredient: DIKLOFENAK

Notice details →
Czechia

DIPROSALIC 0,5MG/G+20MG/G DRM SOL 30ML

Unterbrechung des Inverkehrbringens · Commercial/marketing reasons
Active ingredient: BETAMETHASON

Notice details →
Czechia

FOSAVANCE 70MG/5600IU TBL NOB 12

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: KYSELINA ALENDRONOVÁ A CHOLEKALCIFEROL

Notice details →
Czechia

FYZIOLOGICKÝ ROZTOK VIAFLO 9G/L INF SOL 30X250ML

Marketing resumed · Not specified
Active ingredient: ELEKTROLYTY

Notice details →
Czechia

INVEGA 9MG TBL PRO 49 III

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: PALIPERIDON

Notice details →
Czechia

MOPETIA 100MG INJ SUS PRO ISP 1+2BJ

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: PALIPERIDON

Notice details →
Czechia

MOPETIA 150MG INJ SUS PRO ISP 1+2BJ

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: PALIPERIDON

Notice details →
Czechia

MOPETIA 50MG INJ SUS PRO ISP 1+2BJ

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: PALIPERIDON

Notice details →
Czechia

MOPETIA 75MG INJ SUS PRO ISP 1+2BJ

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: PALIPERIDON

Notice details →
Czechia

PANTOPRAZOLE ZENTIVA 40MG TBL ENT 98 II

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: PANTOPRAZOL

Notice details →
Czechia

PNEUMOVAX 23 INJ SOL ISP 1X0,5ML+2SJ

Marketing ended · Commercial/marketing reasons
Active ingredient: PNEUMOCOCCUS, PURIFIKOVANÉ POLYSACHARIDOVÉ ANTIGENY

Notice details →
Czechia

SEVELAMER CARBONATE VIATRIS 800MG TBL FLM 180 I

Marketing resumed · Not specified
Active ingredient: SEVELAMER

Notice details →
Czechia

TAMOXIFEN ORIFARM 20MG TBL NOB 100

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: TAMOXIFEN

Notice details →
Czechia

TAPTIQOM 15MCG/ML+5MG/ML OPH GTT SOL 1X3ML

Marketing resumed · Not specified
Active ingredient: TIMOLOL, KOMBINACE

Notice details →
Czechia

YELLOX 0,9MG/ML OPH GTT SOL 1X5ML

Marketing resumed · Not specified
Active ingredient: BROMFENAK

Notice details →
Czechia

ZEPATIER 50MG/100MG TBL FLM 28

Marketing ended · Commercial/marketing reasons
Active ingredient: ELBASVIR A GRAZOPREVIR

Notice details →
Czechia

ARIPIPRAZOLE ACCORD 15MG TBL NOB 28X1

Marketing resumed · Not specified
Active ingredient: ARIPIPRAZOL

Notice details →
Czechia

ARIPIPRAZOLE SANDOZ 15MG TBL NOB 56

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: ARIPIPRAZOL

Notice details →
Czechia

CAELYX PEGYLATED LIPOSOMAL 2MG/ML INF CNC SOL 1X10ML

Marketing resumed · Not specified
Active ingredient: DOXORUBICIN

Notice details →
Czechia

CONTROLOC 40MG INJ PLV SOL 10 H

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: PANTOPRAZOL

Notice details →
Czechia

DASATINIB VIATRIS 50MG TBL FLM 60

Unterbrechung des Inverkehrbringens · Increased demand
Active ingredient: DASATINIB

Notice details →
Czechia

DELIPID PLUS 20MG/10MG CPS DUR 30

Marketing resumed · Not specified
Active ingredient: ROSUVASTATIN A EZETIMIB

Notice details →
Czechia

ENDIARON 250MG TBL FLM 10

Marketing ended · Commercial/marketing reasons
Active ingredient: JINÁ STŘEVNÍ ANTIINFEKTIVA

Notice details →
Czechia

GABANOX 400MG CPS DUR 90

Marketing ended · Commercial/marketing reasons
Active ingredient: GABAPENTIN

Notice details →
Czechia

GAMUNEX 100MG/ML INF SOL 1X50ML II

Marketing resumed · Not specified
Active ingredient: IMUNOGLOBULINY, NORMÁLNÍ LIDSKÉ, PRO INTRAVASKULÁRNÍ APLIKACI

Notice details →
Czechia

GLIMEPIRID MYLAN 2MG TBL NOB 90

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: GLIMEPIRID

Notice details →
Czechia

ISOPTIN SR 240MG TBL PRO 100

Unterbrechung des Inverkehrbringens · Increased demand
Active ingredient: VERAPAMIL

Notice details →
Czechia

JAYDESS 13,5MG IUT INS 1X1

Marketing resumed · Not specified
Active ingredient: NITRODĚLOŽNÍ TĚLÍSKO S PROGESTINEM

Notice details →
Czechia

NIMOTOP S 30MG TBL FLM 100 III

Marketing resumed · Not specified
Active ingredient: NIMODIPIN

Notice details →
Czechia

NUSTENDI 180MG/10MG TBL FLM 28

Marketing resumed · Not specified
Active ingredient: KYSELINA BEMPEDOOVÁ A EZETIMIB

Notice details →
Czechia

REMIFENTANIL B. BRAUN 1MG INJ/INF PLV CSL 5

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: REMIFENTANIL

Notice details →
Czechia

RETACRIT 10000IU/1ML INJ SOL ISP 6X1ML I

Marketing ended · Převod registrace
Active ingredient: ERYTROPOETIN

Notice details →
Czechia

RETACRIT 1000IU/0,3ML INJ SOL ISP 6X0,3ML I

Marketing ended · Převod registrace
Active ingredient: ERYTROPOETIN

Notice details →
Czechia

RETACRIT 2000IU/0,6ML INJ SOL ISP 1X0,6ML I

Marketing ended · Převod registrace
Active ingredient: ERYTROPOETIN

Notice details →
Czechia

RETACRIT 2000IU/0,6ML INJ SOL ISP 6X0,6ML I

Marketing ended · Převod registrace
Active ingredient: ERYTROPOETIN

Notice details →
Czechia

RETACRIT 3000IU/0,9ML INJ SOL ISP 6X0,9ML I

Marketing ended · Převod registrace
Active ingredient: ERYTROPOETIN

Notice details →
Czechia

RETACRIT 4000IU/0,4ML INJ SOL ISP 6X0,4ML I

Marketing ended · Převod registrace
Active ingredient: ERYTROPOETIN

Notice details →
Czechia

TALIZON 50MCG/G+0,5MG/G GEL 1X60G

Marketing resumed · Not specified
Active ingredient: KALCIPOTRIOL, KOMBINACE

Notice details →
Czechia

VEROGALID ER 240MG TBL PRO 30

Marketing resumed · Not specified
Active ingredient: VERAPAMIL

Notice details →
Czechia

ZOLPIDEM VIATRIS 10MG TBL FLM 100

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: ZOLPIDEM

Notice details →
Czechia

ARIPIPRAZOLE SANDOZ 10MG TBL NOB 28

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: ARIPIPRAZOL

Notice details →
Czechia

ATORIS 10MG TBL FLM 30

Marketing resumed · Not specified
Active ingredient: ATORVASTATIN

Notice details →
Czechia

AULIN 100MG POR GRA SUS 15 I

Marketing resumed · Not specified
Active ingredient: NIMESULID

Notice details →
Czechia

AXUMIN 1600MBQ/ML INJ SOL 1(1-10ML) II

Unterbrechung des Inverkehrbringens · Commercial/marketing reasons
Active ingredient: FLUCIKLOVIN-(18F)

Notice details →
Czechia

AXUMIN 3200MBQ/ML INJ SOL 1(1-10ML) II

Unterbrechung des Inverkehrbringens · Commercial/marketing reasons
Active ingredient: FLUCIKLOVIN-(18F)

Notice details →
Czechia

CABAZITAXEL SANDOZ 10MG/ML INF CNC SOL 1X6ML

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: KABAZITAXEL

Notice details →
Czechia

CHLORID SODNÝ B.BRAUN 0,9% 9MG/ML INF SOL 10X500ML II

Marketing resumed · Not specified
Active ingredient: ELEKTROLYTY

Notice details →